These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4444228)

  • 41. [Regular monitoring of the levels of protein catabolism and phenols in chronic renal insufficiency].
    Erben J; Zahradník J; Hájková B; Fixa P; Herout V; Brátová M
    Cas Lek Cesk; 1986 Aug; 125(34):1060-4. PubMed ID: 3756996
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of the plasma substitutes hydroxyethyl starch and dextrane-60 on the kidney function of dogs in acute haemorrhagic shock (author's transl)].
    Heidenreich O; aus der Mühlen K; Heintze K
    Anaesthesist; 1975 May; 24(5):239-43. PubMed ID: 56906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of end-stage renal insufficiency in 1976 (author's transl)].
    Leski M
    Schweiz Rundsch Med Prax; 1976 Apr; 65(16):463-5. PubMed ID: 790372
    [No Abstract]   [Full Text] [Related]  

  • 44. [Management of patients with chronic renal failure in the Instituto Nacional de Pediatria, D.I.F. (author's transl)].
    Zaltzman S; Ruiz Speare O; Guzmán Flores A; Jiménez Angulo RM; García de la Puente S
    Rev Invest Clin; 1980; 32(4):443-9. PubMed ID: 7012973
    [No Abstract]   [Full Text] [Related]  

  • 45. [END-STAGE RENAL DISEASE, DIALYSIS TREATMENT AND MANAGEMENT OF COMORBIDITY].
    Klarić D
    Acta Med Croatica; 2016 Dec; 70(4-5):241-7. PubMed ID: 29087139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Body fluids balance in chronic hemodialysis patients].
    Kinouchi T; Koide K; Shimizu N
    Nihon Rinsho; 1992 Jan; 50 Suppl():465-74. PubMed ID: 1578725
    [No Abstract]   [Full Text] [Related]  

  • 47. How Does a Patient's Primary Renal Disease Impact Chronic Dialysis Management?: Primary Renal Diseases and Renal Recovery.
    Chan DT; Chan CT
    Semin Dial; 2015; 28(5):468-70. PubMed ID: 26015085
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hearing acuity evaluation in patients dialysed for chronic renal failure (author's transl)].
    Zakościelna L; Ukleja Z; Nartowicz E; Rajewski W
    Otolaryngol Pol; 1982; 36(2-3):147-53. PubMed ID: 7110727
    [No Abstract]   [Full Text] [Related]  

  • 49. [The influence of l-histidine substitution on protein metabolism (transferrin and complement system) and renal anaemia in endstage renal failure (author's transl)].
    Kult J; Röckel A; Hennemann H; Heidland A
    Med Klin; 1974 Nov; 69(45):1845-9. PubMed ID: 4444649
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].
    Wernze H; Wagner F
    Klin Wochenschr; 1973 Sep; 51(18):933-5. PubMed ID: 4762194
    [No Abstract]   [Full Text] [Related]  

  • 51. [Methylguanidine (MG) movement of serum and urine in chronic renal failure (author's transl)].
    Ishizaki M; Aoyama K; Uno C; Kobayashi S; Asano H; Takahashi H; Momma H; Sekino H; Shishito S; Saito H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):175-84. PubMed ID: 470228
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dialysis and renal transplantation in Switzerland 1975 (author's transl)].
    Brunner FP; Thiel G
    Schweiz Rundsch Med Prax; 1978 Apr; 67(17):620-9. PubMed ID: 347429
    [No Abstract]   [Full Text] [Related]  

  • 53. Urinary catecholamine excretion in relation to renal function.
    Payne RB
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():228-9. PubMed ID: 10735371
    [No Abstract]   [Full Text] [Related]  

  • 54. [Present status of dialysis therapy in Hokkaido (author's transl)].
    Ogawa H
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):489-93. PubMed ID: 7024076
    [No Abstract]   [Full Text] [Related]  

  • 55. [Vitamin D3 metabolism in renal failure (author's transl)].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1978 Jul; 67(7):683-93. PubMed ID: 212493
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessing the Adequacy of Small Solute Clearance for Various Dialysis Modalities, with Inclusion of Residual Native Kidney Function.
    Chin AI; Depner TA; Daugirdas JT
    Semin Dial; 2017 May; 30(3):235-240. PubMed ID: 28194810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in blood coagulation mechanism in patients with chronic renal failure kept on chronic or iterative hemodialysis (author's transl)].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1977 May; 99(5):307-10. PubMed ID: 886907
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acute renal failure after intracranial injury in three children: analysis of possible causes (author's transl)].
    Brandis M; Krohn HP; Offner G; Onken D; Brodehl J
    Dtsch Med Wochenschr; 1975 May; 100(22):1244-7. PubMed ID: 1169145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chronic renal failure and arterial hypertension with "favourable" and "unfavourable" response to haemodialysis--haemodynamic changes in patients (author's transl)].
    Tomásek R; Horký K; Ort J; Lachmanová J; Straková M; Benes R
    Cas Lek Cesk; 1980 Aug; 119(33-34):897-902. PubMed ID: 7438159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.